The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
As the nations bill for drug and genetic tests has climbed to an estimated $8.5 billion a year, theres mounting suspicion among health insurers that some testing may do more to boost profit margins than help treat patients.